About This Event
BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company pioneering the use of artificial intelligence to develop transformative medicines in neuroscience, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Vimal Mehta, Ph.D., CEO of BioXcel Therapeutics, rings the Closing Bell.